Clinical Trials
- Children's Health, Endocrine System, Immune System
Study to investigate adipocyte cell and lipid turnover in obese adolescents
- Ages12 years - 21 years
- GenderBoth
- Liver, Obesity & Weight Management
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
- Ages12 years - 18 years
- GenderBoth
- Liver, Obesity & Weight Management
Effects of Hepatic Ultrasound on Metabolic Homeostasis
- Ages18 years - 60 years
- GenderBoth
- Digestive System, Obesity & Weight Management
Treatments to Treat Loss-of-Control Eating and Improve Weight Outcomes after Bariatric Surgery
- Obesity & Weight Management
Yale Dietary Supplement and Weight Management Study
- Ages18 years - 55 years
- GenderBoth
- Obesity & Weight Management
Preventing Obesity in Preterm Infants
- Liver
A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis (NATiV3)
- Ages18 years and older
- GenderBoth
- Women's Health
Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis (PREGnant)
- Ages18 years - 38 years
- GenderFemale only
- Obesity & Weight Management
Imaging cortisol metabolism in liver, adipose tissue and brain with a novel PET radioligand
- Diabetes
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
- Ages10 years - 17 years
- GenderBoth